Yating Gao

ORCID: 0000-0002-6991-5714 · 3 papers in corpus · active 2021-2025

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 3
other 2025
Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis
Frontiers in immunology ·doi:10.3389/fimmu.2025.1741271

[This corrects the article DOI: 10.3389/fimmu.2021.641206.].

article 2021
An In-Silico, In-Vitro and In-Vivo Combined Approach to Identify NMNATs as Potential Protein Targets of ProEGCG for Treatment of Endometriosis
Frontiers in pharmacology ·doi:10.3389/fphar.2021.714790

Endometriosis is defined as endometrial tissues found outside the uterine cavity. ProEGCG is a prodrug of Epigallocatechin gallate (EGCG), a potent polyphenol found in green tea. It inhibits the development of endometriotic lesions of mouse…

article 2021
Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
Frontiers in immunology ·doi:10.3389/fimmu.2021.641206

Endometriosis is a common, benign, and hormone-dependent gynaecological disorder that displays altered immunoinflammatory profiles. Myeloid-derived suppressor cells (MDSCs) suppressed immunosurveillance in endometriosis in human and mouse m…